A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

January 31, 2007

Conditions

Type 2 Diabetes

Interventions

DRUG

E1 and G1

Trial Locations (3)

Profil Institute for Clinical Research Inc., Chula Vista

Clinical Research of West Florida, Clearwater

Diabetes and Glandular Disease Research Associates, San Antonio

All Listed Sponsors

lead

OPKO Health, Inc.

INDUSTRY

NCT00239187 - A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1 | Biotech Hunter | Biotech Hunter